|
13G/A
|
Montanova Capital, LLC
|
ABEO
Abeona Therapeutics Inc.
|
Healthcare |
—
|
$294M |
-0.8%
|
+3.7%
|
-0.5%
|
-2.8%
|
+2.2%
|
|
13G/A
|
Divisadero Street Capital Management, LP
|
RSI
Rush Street Interactive, Inc
|
Consumer Cyclical |
—
|
$4.9B |
-0.5%
|
-3.5%
|
+4.8%
|
-0.4%
|
+0.7%
|
|
13G/A
|
Divisadero Street Capital Management, LP
|
DAVEW
Dave Inc.
|
— |
—
|
— |
-4.0%
|
-9.7%
|
+41.5%
|
-21.7%
|
+11.8%
|
|
13G/A
|
Divisadero Street Capital Management, LP
|
BBW
Build-a-Bear Workshop, Inc
|
Consumer Cyclical |
—
|
$319M |
-0.4%
|
-2.0%
|
+5.7%
|
-4.5%
|
+2.9%
|
|
13G/A
|
Divisadero Street Capital Management, LP
|
OMDA
Omada Health, Inc.
|
Healthcare |
—
|
$1.2B |
-1.2%
|
+0.0%
|
+3.0%
|
-3.1%
|
+0.8%
|
|
13G/A
|
Divisadero Street Capital Management, LP
|
CTRN
Citi Trends, Inc.
|
Consumer Cyclical |
—
|
$422M |
-1.7%
|
-1.0%
|
-1.4%
|
-1.1%
|
+2.2%
|
|
13G/A
|
Divisadero Street Capital Management, LP
|
KRUS
KURA SUSHI USA, INC.
|
Consumer Cyclical |
—
|
$476M |
-4.4%
|
-0.9%
|
+0.1%
|
-2.9%
|
-0.8%
|
|
13G/A
|
Divisadero Street Capital Management, LP
|
CODI-PA
Compass Diversified Holdings
|
— |
—
|
— |
+0.0%
|
+0.0%
|
+1.0%
|
-0.1%
|
-0.4%
|
|
13G/A
|
CastleKnight Master Fund LP
|
INVLW
Innventure, Inc.
|
— |
—
|
— |
—
|
—
|
—
|
—
|
—
|
|
13G/A
|
CastleKnight Master Fund LP
|
KLXE
KLX Energy Services Holdings
|
Energy |
—
|
$30M |
-3.0%
|
-1.9%
|
+3.2%
|
+0.0%
|
-3.7%
|
|
13G/A
|
CastleKnight Master Fund LP
|
HAIN
HAIN CELESTIAL GROUP INC
|
Consumer Defensive |
—
|
$45M |
-3.7%
|
-6.5%
|
+20.1%
|
-0.9%
|
+27.6%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
AVTX
Avalo Therapeutics, Inc.
|
Healthcare |
—
|
$819M |
+1.8%
|
-1.2%
|
+5.3%
|
-4.5%
|
+0.1%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
CGEM
Cullinan Therapeutics, Inc.
|
Healthcare |
—
|
$936M |
+1.2%
|
+1.2%
|
+8.1%
|
-5.1%
|
+1.4%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
IMA
ImageneBio, Inc.
|
Healthcare |
—
|
$52M |
-4.5%
|
+1.8%
|
+0.2%
|
-1.4%
|
-1.8%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
IVVD
Invivyd, Inc.
|
Healthcare |
—
|
$250M |
+2.7%
|
+17.2%
|
+10.5%
|
-0.9%
|
+4.8%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
NKTR
NEKTAR THERAPEUTICS
|
Healthcare |
—
|
$1.7B |
-0.5%
|
+1.3%
|
+3.3%
|
-2.0%
|
-0.7%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
OKUR
OnKure Therapeutics, Inc.
|
Healthcare |
—
|
$105M |
+3.0%
|
+2.4%
|
-3.1%
|
-3.7%
|
+0.3%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
PVLA
PALVELLA THERAPEUTICS, INC.
|
Healthcare |
—
|
$2.0B |
-1.7%
|
-2.0%
|
-0.3%
|
-4.9%
|
-0.4%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
TCRX
TScan Therapeutics, Inc.
|
Healthcare |
—
|
$19M |
+0.6%
|
+5.3%
|
-9.1%
|
+3.5%
|
+0.4%
|
|
13G/A
|
BIOTECHNOLOGY VALUE FUND L P
|
TENX
TENAX THERAPEUTICS, INC.
|
Healthcare |
—
|
$49M |
-5.0%
|
-0.6%
|
+11.8%
|
-6.3%
|
-1.7%
|